Impact of BREXIT on UK Gene and Cell Therapy: The Need for Continued Pan-European Collaboration

Human Gene Therapy - United States
doi 10.1089/hum.2016.29033.ahb
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Assessing the Impact of Brexit on the European Union

2019English

The Future of European Integration and Brexit: Is Brexit Only Brexit?

Acta Oeconomica
EconomicsEconometrics
2016English

Call for Submissions for the 2020 European Society of Gene and Cell Therapy (ESGCT) Special Issue: Gene and Cell Therapy for Inherited and Acquired Immune Deficiency

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2020English

Brexit and the EMA: What's Next for the UK?

Prescriber
Pharmacology
2017English

The Continued Need for Independent Research on Prescription Drugs

Health Affairs
MedicineHealth Policy
2004English

Brexit and the Future of UK Capitalism

Political Quarterly
SociologyPolitical Science
2019English

Renegotiation of Trade Agreements and Firm Exporting Decisions: Evidence From the Impact of Brexit on UK Exports

SSRN Electronic Journal
2018English

The Impact of Brexit on Pharmaceuticals and HTA

PharmacoEconomics - Open
Health PolicyPharmacology
2018English

The Impacts of Brexit on European Equity Markets

Financial Assets and Investing
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy